David F. Gerrard

David Francis Gerrard (born 3 April 1945 in Auckland) is a sports administrator, sports medicine specialist, and former Olympic Games swimming representative from New Zealand.

Swimming career As a competitive swimmer, Gerrard was a specialist in the butterfly stroke winning the national 110 yards title from 1962 to 1968 (excluding 1964) and the 220 yards title for ten consecutive years from 1960 to 1969.

As a representative at the Olympic Games Gerrard competed at the 1964 Summer Olympics, reaching the semi-finals of the 200 metres butterfly. He also represented New Zealand twice at the British Empire and Commonwealth Games. At the 1962 Games in Perth, Western Australia, he reached the finals in both the 110 yards and 220 yards butterfly but did not medal.

He joined the University of Otago in 1981 and in 2007 Gerrard had become the Associate Dean of the School of Medicine and Associate Professor of Sports Medicine at the University of Otago Dunedin School of Medicine. In the 2007 Queen’s Birthday Honours, he was appointed a Companion of the New Zealand Order of Merit, for services to sports medicine.

In 2014, Gerrard was promoted to professor at the University of Otago Dunedin School of Medicine, and in 2016 was granted the title Emeritus Professor.

Sports administrator Gerrard served as an official at the following Olympic and Commonwealth Games: 1974 Commonwealth Games: Swimming Manager 1982 Commonwealth Games: Team Doctor 1984 Summer Olympics: Team Doctor 1986 Commonwealth Games: Team Doctor 1988 Summer Olympics: Health Team Leader 1994 Commonwealth Games: Chef de Mission 1996 Summer Olympics: Chef de Mission

In the 1995 New Year Honours, Gerrard was appointed an Officer of the Order of the British Empire, for services to sports medicine and sport. He was chair of Drug Free Sport New Zealand from 2003 to 2010. He was one of the inaugural NZ Fellows of the Australasian College of Sport and Exercise Physicians.

He was on the committee of the International Swimming Federation's Sports Medicine Committee for 30 years and has chaired the Therapeutic Use Exemptions committee of the World Anti-Doping Agency since 2013. He is currently working to develop a test to detect use of synthetic Erythropoietin, a drug frequently used in Blood doping.